EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 8

Stevia Stevia rebaudiana (Bertoni) Bertoni

Also called: stevia leaf, steviol glycosides, rebaudioside A, stevioside, Eupatorium rebaudianum (synonym)

Stevia is a South American plant whose leaves contain intensely sweet steviol glycosides (rebaudiosides and stevioside). Highly purified steviol glycosides are used as sweeteners; whole stevia leaf and crude extracts have a different US regulatory status.

Category
Botanical
Part used
Leaf; sweeteners use purified steviol glycosides (at least 95% purity)
Strongest evidence
C Limited
Native range
Native from Brazil (Minas Gerais, Mato Grosso do Sul) to Paraguay (POWO)
Reviewed
2026-10-29

Class 1 Well studied in people. A 2019 meta-analysis (Nutrients) pooled 9 RCTs from 7 studies (462 participants) of steviol glycosides versus placebo. [2]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

3 topics studied2 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Stevia does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Stevia, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood pressureCA 2019 meta-analysis of nine RCTs (462 participants) called a systolic reduction versus placebo (mean difference -6.32 mm Hg) significant, though its reported confidence interval (-7.69 to 0.46) includes zero; the diastolic change was not significant, and heterogeneity was significant. [2]
Blood sugar and HbA1cCThe 2019 Bundgaard Anker meta-analysis found no significant effect on HbA1c and only a non-significant reduction in fasting blood glucose. [2]
Blood pressure and fasting glucose (earlier pooled trials)CA 2015 meta-analysis (9 studies, 756 participants) found no significant change in systolic pressure but lower diastolic pressure and fasting glucose; effects were small and heterogeneous, and rebaudioside A showed no significant effect. [3]

Main constituents: Steviol glycosides (rebaudiosides and stevioside), reported to be 200 to 400 times sweeter than table sugar [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

    Upper limits

    • Acceptable daily intake (ADI) for steviol glycosides: 4 mg/kg body weight per day, expressed as steviol equivalents (set by JECFA, as stated by FDA). [1]
    Safety

    Safety and side effects

    • Liver (NIH LiverTox)
      Nothing found

      No published information found in the sources checked.

      Details and sources
    • Pregnancy and breastfeeding
      Lactation: no data exist on the excretion of stevia components into breast milk or on safety and efficacy in nursing mothers or infants …

      1 statement in the profile.

      Details and sources
    • Interactions with medicines
      Nothing found

      No published information found in the sources checked.

      Details and sources
    • Cancer evaluations (IARC, NTP)
      None found

      No IARC or NTP evaluation was found in the lists checked.

      Details and sources
    • FDA new dietary ingredient notifications
      2 on FDA's list

      FDA does not approve dietary supplements. Each entry is one party's filing.

      Details and sources
    • Dose in official monographs
      None found

      No published information found in the sources checked.

      Details and sources
    • Adverse events reported in steviol glycoside trials included abdominal fullness, epigastric pain and dizziness. [3]
    • Breastfeeding: no data exist on stevia components in breast milk or on safety in nursing mothers or infants; LactMed notes that an alternative sweetener with more data may be preferred, especially with a newborn or preterm infant. [4]
    Quality

    Identity, quality and standardization

    • FDA has not questioned GRAS conclusions for high-purity (95% minimum purity) steviol glycosides under the notified conditions of use; the use of stevia leaf and crude stevia extracts is not considered GRAS, and they are subject to an import alert. [1]
    Regulation

    Regulatory status

    • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
    • US Import Alert 45-06 (published 10/23/2026) allows detention without physical examination of stevia leaves, crude stevia-leaf extracts and foods containing them from firms on its Red List. Products labeled as dietary supplements are exempt unless the stevia is labeled for a technical effect; highly purified steviol glycosides (at least 95%) are not subject to the alert. [5]
    • A search of FDA's GRAS Notice Inventory on 2026-10-29 for substance names containing 'stevi' or 'rebaudi' returned 90 notices: FDA had no questions for 85, 4 were pending and 1 was ceased at the notifier's request; the earliest (GRN 252 and 253, rebaudioside A) closed December 17, 2008. [6]
    Profile

    Safety, quality and supply profile

    Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

    Compounds responsible

    Compounds the sources name as the main or characteristic actives.

    • Steviol glycosides (rebaudiosides, including rebaudioside A, and stevioside) Steviol glycosides [P1]

    US status

    What FDA's published records show. FDA does not approve dietary supplements.

    • FDA's published NDI notification list has 2 entries naming stevia (Stevia rebaudiana) (earliest NDI 1 submitted 1995-07-07; most recent NDI 903, steviol derived from stevia leaves, submitted 2015-12-23). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]
    • GRAS: a search of FDA's GRAS Notice Inventory on 2026-10-29 for substance names containing 'stevi' or 'rebaudi' returned 90 notices (FDA had no questions for 85; 4 pending; 1 ceased at the notifier's request). The earliest, GRN 252 and 253 (rebaudioside A purified from Stevia rebaudiana), closed December 17, 2008. [P3]
    • FDA has not questioned GRAS conclusions for high-purity (95% minimum purity) steviol glycosides under the notified conditions of use; the use of stevia leaf and crude stevia extracts is not considered GRAS. [P4]
    • Import Alert 45-06 (published 10/23/2026): stevia leaves, crude stevia-leaf extracts and foods containing them from firms on the alert's Red List may be detained without physical examination. Products labeled as dietary supplements are exempt unless the stevia is labeled for a technical effect; highly purified steviol glycosides (at least 95%) are not subject to the alert. [P5]

    Cancer evaluations (IARC and NTP)

    Evaluations name the exact material tested, which may differ from a supplement.

    • No IARC or NTP carcinogenicity evaluation of stevia (Stevia rebaudiana) or steviol glycosides was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P6]

    Liver (NIH LiverTox)

    • No published information found in the sources checked.

    Interactions with medicines

    • No published information found in the sources checked.

    Alcohol

    • No published information found in the sources checked.

    Interactions with other herbs and supplements

    • No published information found in the sources checked.

    Adulteration and substitution

    • No published information found in the sources checked.

    What a certificate of analysis should cover

    Tests a quality specification for this material would include, with the reason for each.

    • Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P7]
    • Steviol glycoside purity (specification of at least 95% steviol glycosides) with certificate of analysis and manufacturing process information — Import Alert 45-06 exempts highly purified steviol glycosides meeting this specification and asks for this supporting documentation. [P5]

    Supply and conservation

    • Import Alert 45-06 notes that steviol glycosides may also be produced by fermentation technology; where they are produced without using stevia leaves, the alert does not apply. [P5]

    Absorption in people

    • In healthy men given single oral doses, rebaudioside A and stevioside were both converted to steviol glucuronide in plasma (median tmax 12.0 and 8.0 hours; half-life about 14 hours); steviol glucuronide was excreted mainly in urine (59% and 62% of the dose over 72 hours) and steviol in feces. [P8]

    Formulations studied to change absorption

    Human data only.

    • No published information found in the sources checked.

    Dose in official monographs

    As the monograph states it, for its jurisdiction; not personal advice.

    • No published information found in the sources checked.

    Pregnancy and breastfeeding

    • Lactation: no data exist on the excretion of stevia components into breast milk or on safety and efficacy in nursing mothers or infants; LactMed suggests an alternative sweetener with more data may be preferred, especially while nursing a newborn or preterm infant. [P1]

    Sources for this profile

    1. NIH NICHD. Drugs and Lactation Database (LactMed). Stevia (revised 2024-12-15), 2024-12-15. ncbi.nlm.nih.gov
    2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
    3. FDA. GRAS Notice Inventory, search results for substance names containing 'stevi' or 'rebaudi' (accessed 2026-10-29), 2026-10-29. hfpappexternal.fda.gov
    4. U.S. Food and Drug Administration. Aspartame and Other Sweeteners in Food (content current as of 02/27/2025), 2025-02-27. fda.gov
    5. FDA. Import Alert 45-06: Detention without Physical Examination of Stevia Leaves, Crude Extracts of Stevia Leaves and Foods Containing Stevia Leaves or Stevia Extracts (published 10/23/2026), 2026-10-23. accessdata.fda.gov
    6. IARC Monographs. List of Classifications (list last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
    7. eCFR. 21 CFR 111.75 (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
    8. Wheeler A, et al. Pharmacokinetics of rebaudioside A and stevioside after single oral doses in healthy men. Food Chem Toxicol 2008;46 Suppl 7:S54-60 (PMID 18555578), 2008-07. pubmed.ncbi.nlm.nih.gov
    Sources

    Sources

    1. U.S. Food and Drug Administration. Aspartame and Other Sweeteners in Food (content current as of 02/27/2025), 2025-02-27. fda.gov
    2. Bundgaard Anker CC, et al. Effect of steviol glycosides on human health with emphasis on type 2 diabetic biomarkers: a systematic review and meta-analysis of randomized controlled trials. Nutrients 2019;11(9):1965 (PMID 31438580), 2019-08-21. pubmed.ncbi.nlm.nih.gov
    3. Onakpoya IJ, Heneghan CJ. Effect of the natural sweetener, steviol glycoside, on cardiovascular risk factors: a systematic review and meta-analysis of randomised clinical trials. Eur J Prev Cardiol 2015;22(12):1575-87 (PMID 25412840), 2015-12. pubmed.ncbi.nlm.nih.gov
    4. NIH NICHD. Drugs and Lactation Database (LactMed). Stevia (revised 2024-12-15), 2024-12-15. ncbi.nlm.nih.gov
    5. FDA. Import Alert 45-06: Detention without Physical Examination of Stevia Leaves, Crude Extracts of Stevia Leaves and Foods Containing Stevia Leaves or Stevia Extracts (published 10/23/2026), 2026-10-23. accessdata.fda.gov
    6. FDA. GRAS Notice Inventory, search results for substance names containing 'stevi' or 'rebaudi' (accessed 2026-10-29), 2026-10-29. hfpappexternal.fda.gov
    7. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
    8. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Stevia rebaudiana (Bertoni) Bertoni (accessed 2026-10-29). powo.science.kew.org
    A
    Consistent results from several randomized trials or a systematic review of them
    B
    Some positive randomized trials, but small, short, few or inconsistent
    C
    Limited human evidence: single small trials, observational data or mixed results
    D
    Laboratory or animal evidence only; not shown in people
    X
    Well-designed human trials found no meaningful effect

    More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

    Health information notice

    These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

    Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

    EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

    Ready to check what you take?

    Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.